Keyword: Teva Pharmaceutical Industries
Teva will support work on anti-cancer antibodies at the Weizmann Institute of Science while collaborating with Tel Aviv University.
Teva picks Flex's Kalif to replace CFO McClellan; Endo head Campanelli heads out; Hahn gets pick to be FDA chief.
Amneal's Bisaro, CEO out as generics falter; Teva CFO McClellan stepping down; Loxo CEO Bilenker to take over Lilly oncology on interim basis.
AZ nets exec to lead breast cancer R&D; Teva stars in price-fix plot, but attorneys general say others "willingly" joined; EUSA Pharma nabs new execs.
Teva received FDA approval for a fully integrated digital rescue inhaler for patients with asthma and COPD, equipped with built-in sensors.
AbbVie streamlines management team; FDA taps Flatiron exec for oversight post; and PPD beefs up therapeutics team with new leadership.
Teva’s Ajovy became the second drug in the new CGRP inhibitor class to secure an approval.
Xenotransplantation firm eGenesis hires new R&D head; Relay adds execs to chemistry, R&D; and Navidea brings on new CMO focused on imaging.
Teva has begun a limited U.S. launch of its generic EpiPen, at the same price as Mylan’s own authorized generic launched almost two years ago.
89Bio has raised $60 million to advance a stable of small molecules and biologics acquired from Teva.